Health Policy

The Drug Foundation has announced the appointment of Sarah Helm (Kāi Tahu, pākeha) as its new Executive Director. “Sarah is a supremely talented leader, who joins us at a very exciting time. Sarah brings the...

A dedicated senior Māori leadership role has been created in PHARMAC demonstrating the strong commitment PHARMAC has to ensuring equitable health outcomes for Māori. “PHARMAC is committed to upholding the articles of te Tiriti o...

PHARMAC is standardising the way medicines are contracted, providing better support to healthcare professionals when they are prescribing medicines for their patients. “I am pleased to confirm that the Principal Supply Status approach will be implemented...

Researchers from Te Herenga Waka—Victoria University of Wellington have been awarded more than $1 million from the Health Research Council of New Zealand (HRC) to develop the evidence-base for an effective national HPV screening...

A petition calling on the Government to adopt a sustainable funding model that reflects demand for cochlear implants has been launched by the Pindrop Foundation, NCIP and SCIP. The petition currently has 3289 signatures...

Ten University of Otago proposals have been awarded funding through the Health Research Council’s (HRC) new Health Delivery Research Investment round. The 32 research grants are the first of two funding announcements for the...

Two reports by economic thinktank BERL analysing the current illicit marijuana market and how a new legal model would benefit New Zealand were released yesterday. The economic reports were commissioned by the Ministry of Justice...

PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to enable more young people with juvenile idiopathic arthritis to benefit from these medicines. Juvenile idiopathic arthritis (JIA) is an...

PHARMAC is looking at funding two new oral medicines with substantial health benefits for the 50,000 New Zealanders with type 2 diabetes. The medicines are empagliflozin (brand name Jardiance), empagliflozin with metformin (brand name Jardiamet),...

https://www.youtube.com/watch?v=s5oaQv2ock8&t=7s Michel Neeff, ENT and Cochlear Implant Surgeon, questions why only 1 in 20 adults in New Zealand are getting access to life-changing cochlear implant technology. For over 30 years in New Zealand, cochlear implants have...